173 related articles for article (PubMed ID: 23375914)
1. Effects of aminobisphosphonates and thiazides in patients with osteopenia/osteoporosis, hypercalciuria, and recurring renal calcium lithiasis.
Arrabal-Polo MA; Arias-Santiago S; de Haro-Muñoz T; Lopez-Ruiz A; Orgaz-Molina J; Gonzalez-Torres S; Zuluaga-Gomez A; Arrabal-Martin M
Urology; 2013 Apr; 81(4):731-7. PubMed ID: 23375914
[TBL] [Abstract][Full Text] [Related]
2. Re: effects of aminobisphosphonates and thiazides in patients with osteopenia/osteoporosis, hypercalciuria, and recurring renal calcium lithiasis.
Assimos DG
J Urol; 2013 Aug; 190(2):570-1. PubMed ID: 23845341
[No Abstract] [Full Text] [Related]
3. Mineral density and bone remodelling markers in patients with calcium lithiasis.
Arrabal-Polo MA; Arrabal-Martin M; de Haro-Munoz T; Lopez-Leon VM; Merino-Salas S; Ochoa-Hortal MA; Garrido-Gomez J; Lahoz-Garcia C; Zuluaga-Gomez A
BJU Int; 2011 Dec; 108(11):1903-8; discussion 1908. PubMed ID: 21554525
[TBL] [Abstract][Full Text] [Related]
4. Effect of low-dose alendronate treatment on bone mineral density and bone turnover markers in Chinese postmenopausal women with osteopenia and osteoporosis.
Li M; Zhang ZL; Liao EY; Chen DC; Liu J; Tao TZ; Wu W; Xia WB; Lu YJ; Sheng ZF; Lu CY; Meng GL; Xu L; Zhang WJ; Hu YY; Xu L
Menopause; 2013 Jan; 20(1):72-8. PubMed ID: 22968256
[TBL] [Abstract][Full Text] [Related]
5. Retrospective review of serum and urinary lithogenic risk factors in patients with osteoporosis and osteopenia.
Arrabal-Polo MA; Girón-Prieto MS; Cano-García Mdel C; Poyatos-Andujar A; Quesada-Charneco M; Abad-Menor F; Arias-Santiago S; Zuluaga-Gomez A; Arrabal-Martin M
Urology; 2015 Apr; 85(4):782-5. PubMed ID: 25817102
[TBL] [Abstract][Full Text] [Related]
6. Urine Calcium and Bone Mineral Density in Calcium Stone-Forming Patients Treated with Alendronate and Hydrochlorothiazide.
Arrabal-Martín M; González-Torres S; Cano-García MD; De Haro-Muñoz T; Abad-Menor F; Arrabal-Polo MÁ; Cózar-Olmo JM
Urol Int; 2016; 97(3):292-298. PubMed ID: 26800461
[TBL] [Abstract][Full Text] [Related]
7. The importance of calciuria as lithogenic factors in patients with osteopenia/osteoporosis.
Arrabal-Martin M; Poyatos-Andujar A; Cano-García Mdel C; Quesada-Charneco M; Abad-Menor F; Girón Prieto MS; de Haro Muñoz T; Arrabal-Polo MA
Int Urol Nephrol; 2015 Mar; 47(3):445-9. PubMed ID: 25652872
[TBL] [Abstract][Full Text] [Related]
8. Alendronate and indapamide alone or in combination in the management of hypercalciuria associated with osteoporosis: a randomized controlled trial of two drugs and three treatments.
Giusti A; Barone A; Pioli G; Girasole G; Siccardi V; Palummeri E; Bianchi G
Nephrol Dial Transplant; 2009 May; 24(5):1472-7. PubMed ID: 19075192
[TBL] [Abstract][Full Text] [Related]
9. Treatment with hydrochlorothiazide and alendronate in patients with stones and bone mineral density loss. Evolution of bone metabolism and calciuria with medical treatment.
Arrabal-Martín M; González-Torres S; Cano-García MC; Poyatos-Andújar A; Abad-Menor F; Arrabal-Polo MA
Arch Esp Urol; 2016; 69(1):9-18. PubMed ID: 26856738
[TBL] [Abstract][Full Text] [Related]
10. [Clinical application of alendronate for osteoporosis/osteopenia secondary to hyperthyroidism].
Yang LJ; Shen FX; Zheng JC; Zhang HL
Zhongguo Gu Shang; 2012 Feb; 25(2):133-7. PubMed ID: 22577718
[TBL] [Abstract][Full Text] [Related]
11. Alendronate in combination with calcium and vitamin D prevents bone loss after orthotopic liver transplantation: a prospective single-center study.
Millonig G; Graziadei IW; Eichler D; Pfeiffer KP; Finkenstedt G; Muehllechner P; Koenigsrainer A; Margreiter R; Vogel W
Liver Transpl; 2005 Aug; 11(8):960-6. PubMed ID: 16035083
[TBL] [Abstract][Full Text] [Related]
12. [Alendronate and resorptive hypercalciuria].
Arrabal-Polo MA; Arrabal-Martin M; Zuluaga-Gomez A
Med Clin (Barc); 2011 Sep; 137(7):333. PubMed ID: 21543092
[No Abstract] [Full Text] [Related]
13. Calcium renal lithiasis and bone mineral density. Importance of bone metabolism in urinary lithiasis.
Arrabal-Polo MÁ; Sierra Girón-Prieto M; Orgaz-Molina J; Zuluaga-Gómez A; Arias-Santiago S; Arrabal-Martín M
Actas Urol Esp; 2013 Jun; 37(6):362-7. PubMed ID: 23411066
[TBL] [Abstract][Full Text] [Related]
14. Metabolic-mineral study in patients with renal calcium lithiasis, severe lithogenic activity and loss of bone mineral density.
Arrabal-Polo MA; Arrabal-Martin M; Arias-Santiago S; Garrido-Gomez J; De Haro-Muñoz TD; Zuluaga-Gomez A
Singapore Med J; 2012 Dec; 53(12):808-13. PubMed ID: 23268154
[TBL] [Abstract][Full Text] [Related]
15. Alendronate decreases the fracture risk in patients with prostate cancer on androgen-deprivation therapy and with severe osteopenia or osteoporosis.
Planas J; Trilla E; Raventós C; Cecchini L; Orsola A; Salvador C; Placer J; Encabo G; Morote J
BJU Int; 2009 Dec; 104(11):1637-40. PubMed ID: 19549260
[TBL] [Abstract][Full Text] [Related]
16. [Alendronate in postmenopausal women with osteopenia and osteoporosis: effects on bone mineral density during treatment and after withdrawal].
Jiang Y; Li M; Xia W; Xing X; Yu W; Tian J; Meng X; Zhou X
Zhonghua Yi Xue Za Zhi; 2002 Sep; 82(18):1254-6. PubMed ID: 12425805
[TBL] [Abstract][Full Text] [Related]
17. [Effect of thiazide therapy in the prophylaxis of calcium lithiasis].
Fernández Rodríguez A; Arrabal Martín M; García Ruiz MJ; De Haro Muñoz T; Zuluaga Gómez A
Arch Esp Urol; 2001 Nov; 54(9):1047-54. PubMed ID: 11789362
[TBL] [Abstract][Full Text] [Related]
18. Effects of oral alendronate in elderly patients with osteoporosis and mild primary hyperparathyroidism.
Rossini M; Gatti D; Isaia G; Sartori L; Braga V; Adami S
J Bone Miner Res; 2001 Jan; 16(1):113-9. PubMed ID: 11149474
[TBL] [Abstract][Full Text] [Related]
19. Alendronate for steroid-induced osteopenia in children with acute lymphoblastic leukaemia or non-Hodgkin's lymphoma: results of a pilot study.
Wiernikowski JT; Barr RD; Webber C; Guo CY; Wright M; Atkinson SA
J Oncol Pharm Pract; 2005 Jun; 11(2):51-6. PubMed ID: 16460605
[TBL] [Abstract][Full Text] [Related]
20. Calcium nephrolithiasis and bone demineralization: pathophysiology, diagnosis, and medical management.
Arrabal-Polo MA; Cano-García Mdel C; Canales BK; Arrabal-Martín M
Curr Opin Urol; 2014 Nov; 24(6):633-8. PubMed ID: 25188231
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
